

Using fluorescent calcium sensors, Tohoku University researchers have now tracked astrocyte activity and found that it begins about 20 seconds prior to the commencement of epileptic neuronal hyperactivity. This implies that astrocytes have a major role in inducing epileptic seizures by promoting the neuronal circuit’s hyperdrive.
On April 9, 2024, these results were published in full in the journal Glia.
Nearly half of the brain is made up of non-neuronal glial cells called astrocytes. It has been demonstrated that they regulate the metabotropic and ionic conditions locally. However, due to their lack of readily observable electrical activity, their significance in brain function has been generally overlooked. This is being altered by fluorescent sensor proteins, which provide additional insight into the fascinating activity of astrocytes.
“Astrocytes appear to have a determinant role in controlling the state of neuronal activity and synaptic plasticity both in physiological and pathophysiological situations,” said the study’s principal investigator, Professor Ko Matsui of Tohoku University’s Super-network Brain Physiology lab. “Therefore, astrocytes could be considered as a new therapeutic target for epilepsy treatment.”
The astrocyte calcium increased significantly in response to this stimulation, the researchers observed, and this was followed by an epileptic neuronal hyperactivity episode. The amount of epileptic neuronal excitability was greatly decreased when fluorocitrate was applied to the astrocytes to limit their metabolic activity. All of these suggest that astrocytes may be able to regulate neural activity.
Shun Araki, the study’s lead scientist, emphasized that astrocytes’ abilities could be used to treat a variety of neurological disorders with the right direction. This covers epilepsy as well as the possibility of improving cognitive capacities over and above their inherent constraints.
For more information: Astrocyte switch to the hyperactive mode, Glia, DOI: 10.1002/glia.24537
more recommended stories
Creatine May Boost Muscle Strength in Alzheimer’s Patients
Creatine Supplementation Shows Promise in Alzheimer’s.
New Drug STF-1623 Shows Promise in Treating Solid Tumors
STF-1623 Transforming ‘Cold’ Tumors into ‘Hot’.
Macrophage Microautophagy Supports Immune Readiness
A Breakthrough in Cellular Recycling Macrophages,.
The Role of α-Glucosidase in Type 2 Diabetes
α-Glucosidase Inhibition: Functional Food Compounds for.
Oral Bacteria Linked to Atherosclerosis
New Evidence Links Viridans Streptococci to.
CDI Test Shows Early Detection Potential in Alzheimer’s
Breakthrough Study Highlights Brain Blood Flow.
Prenatal Chlorpyrifos Exposure and Pediatric Brain Changes
A Growing Concern in Pediatric Neurodevelopment.
Valve Deterioration After TAVI: New Research Insights
The Growing Role of TAVI in.
FAST Walking Shows Promise in Post-Stroke Rehab
Stroke remains one of the leading.
Legionnaires’ Disease Long-Term Effects on Patient Recovery
Persistent Symptoms and Post-Acute Infection Syndromes.
Leave a Comment